Implementation of DWM in Dutch SMEs

Summary

The goal of this cluster randomized controlled trial is to explore if mental health in Dutch small and medium-sized enterprises (SMEs) can be improved by the World Health Organization's online program Doing What Matters in Times of Stress (DWM). The main questions it aims to answer are: * Does DWM improve the mental health of employees working in Dutch SMEs? * Does DWM improve work-related outcomes in employees working in Dutch SMEs? * How can DWM be implemented at a large scale in Dutch SMEs? Researchers will compare two groups to see if the DWM program is effective. One group will receive the DWM program and Care-as-Usual (group 1), and the other group will receive Care-as-Usual only (group 2). Participants will: * Follow the online DWM program for 5 weeks (only group 1). * Take part in 6 telephone appointments with a facilitator (helper) that provides extra support to complete the program (only group 1). * Complete 3 sets of questionnaires. Each set of questionnaire takes about 15 minutes to be completed (group 1 and group 2).

Eligibility

Inclusion Criteria (SMEs):

* Having 10 to 250 employees
* Being located in the Netherlands
* (In case of insufficient recruitment among SMEs, a mitigation strategy is to recruit individual departments from larger organizations)

Inclusion Criteria (Individual participants):

* 18 years or older
* Having elevated levels of psychological distress (Kessler Psychological Distress Scale; K10 scores \> 15.9)
* Sufficient literacy and mastery (written and spoken) of one of the languages the DWM intervention is being delivered in (i.e., Dutch or English)
* Having access to an electronic device with internet access to follow the intervention
* Written informed consent before entering the study

Exclusion Criteria (Individual participants):

* Imminent suicide risk, or expressed acute needs or protection risks that require immediate follow-up
* Currently receiving specialized psychological treatment (e.g., EMDR or CBT) at the time of screening
* In case of current psychotropic medication use: being on an unstable dose for at least 2 months or a change in dosage over the past 2 months.
* Having participated in the preceding ASCEND trial as supervisor (see NCT ID: NCT06989398)

Conditions3

Browse More Trials